Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 14 hours 13 min ago

C-Suite Shuffle: A2 Bio, Bayer, BioNTech and More

Wed, 03/27/2024 - 02:00
C-Suite Shuffle: A2 Bio, Bayer, BioNTech and More 3/27/2024

Opinion: Biopharma Should Prioritize Research on the Economics of Therapies

Wed, 03/27/2024 - 02:00
Opinion: Biopharma Should Prioritize Research on the Economics of Therapies 3/27/2024

In an Evolving Market, HR Leaders Balance Business Needs with Employee Engagement

Wed, 03/27/2024 - 02:00
In an Evolving Market, HR Leaders Balance Business Needs with Employee Engagement 3/27/2024

FDA Approves Potential 'Game Changer' for Pulmonary Arterial Hypertension

Tue, 03/26/2024 - 02:00
FDA Approves Potential 'Game Changer' for Pulmonary Arterial Hypertension 3/26/2024

Viking Touts Promising Phase I Data for Weight-Loss Pill Candidate

Tue, 03/26/2024 - 02:00
Viking Touts Promising Phase I Data for Weight-Loss Pill Candidate 3/26/2024

Brazil and Caring Cross to Produce Affordable CAR-T, Stem Cell Gene Therapies

Tue, 03/26/2024 - 02:00
Brazil and Caring Cross to Produce Affordable CAR-T, Stem Cell Gene Therapies 3/26/2024

AstraZeneca’s Ultomiris Wins FDA Approval for Rare Autoimmune Disease

Tue, 03/26/2024 - 02:00
AstraZeneca’s Ultomiris Wins FDA Approval for Rare Autoimmune Disease 3/26/2024

Stoke’s Early-Stage Data for Genetic Epilepsy Drug Sends Stock Skyrocketing

Tue, 03/26/2024 - 02:00
Stoke’s Early-Stage Data for Genetic Epilepsy Drug Sends Stock Skyrocketing 3/26/2024

Axsome Therapeutics’ Small Molecule Clears Phase III Trial in Narcolepsy

Tue, 03/26/2024 - 02:00
Axsome Therapeutics’ Small Molecule Clears Phase III Trial in Narcolepsy 3/26/2024

BioNTech Hit with NIH Notice of Default Over COVID-19 Vaccine Royalties

Tue, 03/26/2024 - 02:00
BioNTech Hit with NIH Notice of Default Over COVID-19 Vaccine Royalties 3/26/2024

FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma

Mon, 03/25/2024 - 02:00
FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma 3/25/2024

Novo’s $1.1B Cardior Buy Continues Expansion into Heart Disease

Mon, 03/25/2024 - 02:00
Novo’s $1.1B Cardior Buy Continues Expansion into Heart Disease 3/25/2024

AbbVie Acquires Landos in Potential $212M Deal, Bolsters Anti-Inflammatory Pipeline

Mon, 03/25/2024 - 02:00
AbbVie Acquires Landos in Potential $212M Deal, Bolsters Anti-Inflammatory Pipeline 3/25/2024

J&J Wins FDA Nod for Pulmonary Arterial Hypertension Combo Pill

Mon, 03/25/2024 - 02:00
J&J Wins FDA Nod for Pulmonary Arterial Hypertension Combo Pill 3/25/2024

FDA Authorizes Invivyd’s Pemgarda to Prevent COVID-19 in Immunocompromised People

Mon, 03/25/2024 - 02:00
FDA Authorizes Invivyd’s Pemgarda to Prevent COVID-19 in Immunocompromised People 3/25/2024

AbbVie Secures Full FDA Approval for ADC Elahere in Ovarian Cancer

Mon, 03/25/2024 - 02:00
AbbVie Secures Full FDA Approval for ADC Elahere in Ovarian Cancer 3/25/2024

Esperion Targets Seven-Fold Jump in Cholesterol Drug Population with FDA Label Expansion

Mon, 03/25/2024 - 02:00
Esperion Targets Seven-Fold Jump in Cholesterol Drug Population with FDA Label Expansion 3/25/2024

Wegovy Cardiovascular Approval Furthers March into New Indications

Mon, 03/25/2024 - 02:00
Wegovy Cardiovascular Approval Furthers March into New Indications 3/25/2024

Epigenetic Editing Explodes on the Heels of Gene Editing Success

Mon, 03/25/2024 - 02:00
Epigenetic Editing Explodes on the Heels of Gene Editing Success 3/25/2024

Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology

Mon, 03/25/2024 - 02:00
Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology 3/25/2024